Glycomic Therapeutics Market Scope And Analysis

  • Report Code : TIPRE00029576
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 330
Buy Now

Glycomic Therapeutics Market Size and Scope by 2031

Buy Now

Glycomic Therapeutics Market Report Glycomic Therapeutics Market Size and Share Glycomic Therapeutics Market Scope and Analysis

Glycomic Therapeutics Market Report Scope

Report Attribute Details
Market size in 2021 US$ 99.02 Billion
Market Size by 2028 US$ 257.58 Billion
Global CAGR (2021 - 2028) 15.8%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Class
  • Isolated and Synthetic
By Structures
  • Glycoproteins
  • Targeting Sialic Acid
  • Proteoglycans
  • Targeting Glycosaminoglycans
  • Glycosylphosphatidylinositol-Anchored Proteins & Heparin Based Glycans
  • Targeting Glycosphingolipids
By Indications
  • Thrombosis & Chemoprophylaxis
  • Anaemia
  • Anti-Adhesive & Anti-Inflammatory
  • Cataracts
  • Gaucher
By Mode of Action
  • Inhibits Neuraminidase
  • Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate
  • Erythropoietin & Enzyme Replacement Therapy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Intellihep Ltd
  • Protalix Biotherapeutics
  • BioMarin Pharmaceutical Inc
  • Genzyme Corporation Sanofi
  • Halozyme Therapeutics Inc
  • Bayer AG
  • Alzheon Inc
  • GlycoMar
  • GlaxoSmithKline plc